Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Tubulocystic renal cell carcinoma is an extremely rare subtype of renal cell carcinoma most frequently characterized by a small, solitary, well-circumscribed, unencapsulated renal tumor composed of multiple small to medium-sized cysts with a white or gray, spongy ("bubble wrap-like") cut surface. Patients are usually asymptomatic or could manifest with abdominal pain, abdominal distension and/or hematuria. Progression, recurrence and metastasis rarely occur although lymph node, bone, pleura and liver mestatsis have been reported.
Biomarker and diagnostic research for tubulocystic renal cell carcinoma has been reported in the published literature.
No clinical trials have been registered for tubulocystic renal cell carcinoma.
12 publications have been identified in PubMed for tubulocystic renal cell carcinoma. Research spans Case Report / Case Series (58%), Other (17%), and Diagnostic / Biomarker (8%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 | 58% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 7:27 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
2 |
17% |
Testing and diagnosis research | 1 | 8% |
Research summaries | 1 | 8% |
Laboratory research | 1 | 8% |
Sangoi AR (2026). [PMID: 41513005](https://pubmed.ncbi.nlm.nih.gov/41513005/). *Hum Pathol*. [Other]
Choi R (2026). [PMID: 42044518](https://pubmed.ncbi.nlm.nih.gov/42044518/). *Ultrasound Q*. [Diagnostic / Biomarker]
AbuHaweeleh MN (2026). [PMID: 42166387](https://pubmed.ncbi.nlm.nih.gov/42166387/). *Urol Int*. [Review / Meta-Analysis]
Harik LR (2025). [PMID: 40728275](https://pubmed.ncbi.nlm.nih.gov/40728275/). *Am J Surg Pathol*. [Case Report / Case Series]
Feng W (2025). [PMID: 40696168](https://pubmed.ncbi.nlm.nih.gov/40696168/). *Oncogene*. [Basic Science / Preclinical]
Ding YS (2025). [PMID: 40171229](https://pubmed.ncbi.nlm.nih.gov/40171229/). *Urol Case Rep*. [Case Report / Case Series]
Ghadieh A (2025). [PMID: 40114195](https://pubmed.ncbi.nlm.nih.gov/40114195/). *J Med Case Rep*. [Case Report / Case Series]
Sakano Y (2025). [PMID: 40343648](https://pubmed.ncbi.nlm.nih.gov/40343648/). *Jpn J Radiol*. [Other]
Chen S (2024). [PMID: 39371548](https://pubmed.ncbi.nlm.nih.gov/39371548/). *J Clin Imaging Sci*. [Case Report / Case Series]
Xiao GQ (2024). [PMID: 39703302](https://pubmed.ncbi.nlm.nih.gov/39703302/). *Cureus*. [Case Report / Case Series]